| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/04/2001 | US6284882 Myostatin gene promoter and inhibition of activation thereof |
| 09/04/2001 | US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases |
| 09/04/2001 | US6284880 A dna molecule coding for a gene that has anti-apoptotic effects; for transfection of eukaryotic cells without toxic effects |
| 09/04/2001 | US6284872 Tendon-inducing compositions |
| 09/04/2001 | US6284870 Gamma retinoic acid receptor |
| 09/04/2001 | US6284743 Method for modulating smooth muscle cell proliferation |
| 09/04/2001 | US6284742 Administering adenovirus and antibodies |
| 09/04/2001 | US6284740 Osteoprotegerin |
| 09/04/2001 | US6284728 Osteoprotegerin |
| 09/04/2001 | US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence |
| 09/04/2001 | US6284539 Method for generating dopaminergic cells derived from neural precursors |
| 09/04/2001 | US6284537 Determining mutagenicity, toxicity or beneficial effects of agent on the metabolism |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284511 Generating mutant dna sequence library; screening |
| 09/04/2001 | US6284508 Glucuronoxylomannan (GXM)-O-acetylhydrolase of Cryptococcus neoformans and uses thereof |
| 09/04/2001 | US6284507 Mitofusin genes and their uses |
| 09/04/2001 | US6284506 3-Hydroxy-3-methylglutaryl-CoA reductase polynucleotides in isoprenoid production |
| 09/04/2001 | US6284503 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 09/04/2001 | US6284492 Recombinant animal viral nucleic acids |
| 09/04/2001 | US6284491 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 09/04/2001 | US6284489 Enzymatic polypeptide for use in screening bactericides; wound healing agents; for prevention of bacterial infections |
| 09/04/2001 | US6284485 Nucleic acids encoding osteoprotegerin |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284469 RNA export element and methods of use |
| 09/04/2001 | US6284458 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 09/04/2001 | US6284456 Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor |
| 09/04/2001 | US6284454 Variant of LAV viruses |
| 09/04/2001 | US6284451 Apparatus for propagation of preferential cells |
| 09/04/2001 | US6284284 Injecting human secreted extracellular matrix comprising mixture of cell-free, naturally secreted human extracellular components derived from living stromal tissue by injection via a syringe and carrier at skin defect or tissue defect site |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284252 Transdominant TAT variants of the human immunodeficiency virus |
| 09/04/2001 | US6284245 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 09/04/2001 | US6284242 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 09/04/2001 | US6284240 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 09/04/2001 | US6284239 Murine model for human carcinoma |
| 09/04/2001 | US6282837 Methods of controlling the growth of undesired vegetation with herbicide tolerant plants or plant seeds having altered protoporphyrinogen oxidase activity |
| 09/04/2001 | CA2205430C Method for making a medicament for treating secondary immunodeficiency |
| 09/04/2001 | CA2116753C Monoclonal antibodies recognizing the epidermal growth factor-receptor, cells and methods for producing them and compositions containing them |
| 09/04/2001 | CA1341288C Protein kinase c |
| 08/30/2001 | WO2001063286A2 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 08/30/2001 | WO2001063281A1 Methods of screening for compounds that modulate blood vessel formation |
| 08/30/2001 | WO2001062974A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | WO2001062973A1 Antisense modulation of e2f transcription factor 3 expression |
| 08/30/2001 | WO2001062969A2 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062934A1 Starch branching enzyme |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062929A2 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062919A1 Modified fluorescent proteins |
| 08/30/2001 | WO2001062902A1 Hybrid cell vaccines |
| 08/30/2001 | WO2001062901A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | WO2001062899A2 Method of making embryoid bodies from primate embryonic stem cells |
| 08/30/2001 | WO2001062898A1 Artificial pancreatic islet reconstituted from isolated pancreatic endocrine cells |
| 08/30/2001 | WO2001062897A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines |
| 08/30/2001 | WO2001062895A2 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062770A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | WO2001062725A2 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062207A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/30/2001 | WO2001026458A3 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 08/30/2001 | WO2001012806A3 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 08/30/2001 | WO2001012783A3 Motile sperm separation by cellulose derivatives |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001012127A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 08/30/2001 | WO2001009187A3 Human monoclonal antibodies to her2/neu |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2001002540A3 Adenoviral vectors for treating disease |
| 08/30/2001 | WO2000073794A3 Method for separating cells using immunorosettes |
| 08/30/2001 | WO2000066750A3 Methods for producing plants with elevated oleic acid content |
| 08/30/2001 | WO2000050572A9 Use of collagenase in the preparation of neural stem cell cultures |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | US20010018773 Production of cotton fiber with improved fiber characteristics |
| 08/30/2001 | US20010018414 Modified vitamin K-dependent polypeptides |
| 08/30/2001 | US20010018214 Culturing retrovirally infected eukaryotic cells in aseptic, low oxygen conditions; bacteria produced contain eukaryotic and viral genes |
| 08/30/2001 | US20010018213 Method to obtain immortalized cell lines from primary cultured human keratinocytes |
| 08/30/2001 | US20010018212 Molecular weight of 14,000 to 24,000 daltons; treating infectious diseases and malignant tumors with said protein |
| 08/30/2001 | US20010018210 Contacting cells with dipeptidyl peptidase inhibitor immobilized by attachment to container or magetic particle or as part of heteroconjugate with antigenic peptide |
| 08/30/2001 | US20010018209 Hematopoietic stem cells from which cancer cells have been eliminated with apoptosis inducer specific to cancer cells; oligosaccharides and derivatives |
| 08/30/2001 | US20010018208 Polynucleotide encoding polypeptide comprising fragment of mammalian aspartyl protease protein (Asp2) with beta-secretase activity; treatment of Alzheimer's disease |
| 08/30/2001 | US20010018207 Dna regulatory element for the expression of transgenes in neurons of the mouse forebrain |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018191 Immunology complex with epitopes; Alzheimer's disease |
| 08/30/2001 | US20010018189 Crohn's disease, skin disorders, antiallergens |
| 08/30/2001 | US20010018186 Method for molecular diagnosis of tumor angiogenesis and metastasis |
| 08/30/2001 | US20010017004 Apparatus for culturing plantlets and process for culturing the same by using said apparatus |
| 08/30/2001 | CA2406864A1 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401096A1 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |